Novartis AG
NYSE:NVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
NYSE:NVS
|
CH |
|
W
|
Western Forest Products Inc
XBER:NWF
|
CA |
|
P
|
Procept Biorobotics Corp
NASDAQ:PRCT
|
US |
|
C
|
City of London Investment Group PLC
OTC:CLIUF
|
UK |
|
Liaoning Port Co Ltd
OTC:DLPTF
|
CN |
|
E
|
Eles Semiconductor Equipment SpA
MIL:ELES
|
IT |
|
Fraport Frankfurt Airport Services Worldwide AG
F:FRAS
|
DE |
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
|
Pfizer Ltd
NSE:PFIZER
|
IN |
|
Perusahaan Gas Negara Tbk PT
OTC:PPAAF
|
ID |
|
I
|
Imax Corp
XBER:IMA
|
CA |
|
Asetek A/S
F:A31
|
DK |
|
User Local Inc
TSE:3984
|
JP |
|
G
|
Guangdong Investment Ltd
F:GUG
|
HK |
|
Appfolio Inc
NASDAQ:APPF
|
US |
|
C
|
CH Robinson Worldwide Inc
SWB:CH1A
|
US |
|
Magazine Luiza SA
OTC:MGLUY
|
BR |
|
Builders FirstSource Inc
NYSE:BLDR
|
US |
Bankruptcy Probability
Novartis AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novartis AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
Novartis AG
SIX:NOVN
|
241B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
616.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
320.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
209.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
132.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
195.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novartis AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novartis AG has total debt of 39.2B USD. This includes both short-term (0 USD) and long-term (39.2B USD) debt.
You can find a full breakdown on its Balance Sheet.
